KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0067 | - |
clonazepam | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0185 | - |
nimetazepam | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0383 | - |
nilutamide | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.046 | - |
flunitrazepam | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.053 | - |
flutamide | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.2014 | - |
nimesulide | liver cytosol, pH 7.4, 37°C | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q06278 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
azelnidipine + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
clonazepam + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
flunitrazepam + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
flutamide + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
nifedipine + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
nilutamide + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
nimesulide + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
nimetazepam + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? | |
nimodipine + H2O + O2 | - |
Homo sapiens | ? + H2O2 | - |
? |
General Information | Comment | Organism |
---|---|---|
metabolism | nitroaromatic drugs clonazepam, flunitrazepam, flutamide, nilutamide, nimesulide, and nimetazepam are substantially reduced by recombinant AOX1 and human liver cytosol, whereas azelnidipine, nifedipine, and nimodipine are slightly reduced and metronidazole and tolcapone are not reduced. Nitroaromatic drugs reduced by AOX1 possess a relatively electron-deficient nitro group | Homo sapiens |